Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro. Baghdad Sci.J [Internet]. 2022 Apr. 1 [cited 2025 Jun. 5];19(2):0255. Available from: https://bsj-ojs.uobaghdad.edu.iq/index.php/BSJ/article/view/5706